Copyright
©The Author(s) 2016.
World J Hepatol. Sep 28, 2016; 8(27): 1137-1148
Published online Sep 28, 2016. doi: 10.4254/wjh.v8.i27.1137
Published online Sep 28, 2016. doi: 10.4254/wjh.v8.i27.1137
Table 1 Characteristics of the study groups at baseline (pre-intervention) and after 6 mo of energy restriction or exercise training (post-intervention)
Energy restriction (n = 6) | Exercise training (n = 10) | |||
Pre | Post | Pre | Post | |
Age (yr) | 45.5 ± 13.5 | 51.8 ± 6.7 | ||
Gender (M:F) | 3:3 | 7:3 | ||
BMI (kg/m2) | 33.5 ± 9.0 | 30.0 ± 7.0a | 31.2 ± 3.2 | 30.8 ± 3.5 |
Fat-mass (%) | 38 ± 9 | 35 ± 11b | 36 ± 7 | 33 ± 6a |
Fat-free mass (kg) | 54.1 ± 12.3 | 51.3 ± 11.8 | 63.1 ± 14.3 | 64.4 ± 14.2a |
Waist (cm) | 106 ± 16 | 90 ± 13 | 110 ± 14 | 105 ± 13a |
Systolic blood pressure (mmHg) | 126 ± 13 | 118 ± 13a | 139 ± 19 | 137 ± 18 |
Subcutaneous adipose tissue (cm2) | 358 ± 282 | 268 ± 202b | 322 ± 116 | 298 ± 117a |
Visceral adipose tissue (cm2) | 202 ± 110 | 203 ± 56b | 182 ± 67 | 117 ± 36a |
Diastolic blood pressure (mmHg) | 83 ± 8 | 75 ± 12 | 88 ± 11 | 83 ± 10 |
Triglycerides (mmol/L) | 1.6 ± 0.8 | 1.1 ± 0.4 | 2.0 ± 1.3 | 2.0 ± 0.2 |
HDL cholesterol (mmol/L) | 0.9 ± 0.2 | 1.0 ± 0.3 | 1.0 ± 0.2 | 1.1 ± 0.2a |
LDL cholesterol (mmol/L) | 3.5 ± 0.8 | 3.0 ± 0.6 | 3.2 ± 1.1 | 3.1 ± 1.0 |
VLDL cholesterol (mmol/L) | 0.7 ± 0.3 | 0.5 ± 0.2b | 0.9 ± 0.6 | 0.7 ± 0.5 |
Free fatty acids (mmol/L) | 0.59 ± 0.15 | 0.63 ± 0.23 | 0.59 ± 0.17 | 0.62 ± 0.25 |
Glucose (mmol/L) | 5.2 ± 0.3 | 5.0 ± 0.7 | 5.5 ± 0.5 | 5.3 ± 0.4 |
Insulin (mU/L) | 18 ± 18 | 10 ± 5 | 24 ± 23 | 12 ± 10 |
M-value (mg/kgFFM per minute) | 4.2 ± 1.4 | 5.2 ± 1.5 | 4.0 ± 0.9 | 5.2 ± 1.6a |
hsCPR (mg/L) | 4.9 ± 3.7 | 2.0 ± 1.6 | 3.9 ± 3.6 | 1.5 ± 1.3 |
Alanine aminotransferase (U/L | 80 ± 65 | 55 ± 55 | 54 ± 19 | 49 ± 28 |
Aspartate aminotransferase (U/L) | 40 ± 22 | 28 ± 16 | 38 ± 11 | 39 ± 22 |
Table 2 Resting substrate metabolism pre-intervention and after 6 mo of energy restriction or exercise training (post-intervention) in patients with non-alcoholic fatty liver disease
Energy restriction (n = 6) | Exercise (n = 10) | |||||
Pre | Post | P | Pre | Post | P | |
Respiratory quotient | 0.82 ± 0.04 | 0.80 ± 0.04 | 0.38 | 0.84 ± 0.06 | 0.81 ± 0.06 | 0.05 |
Fatox (mg/kgFFM per minute) | 1.18 ± 0.25 | 1.46 ± 0.33 | 0.17 | 1.15 ± 0.54 | 1.35 ± 0.48 | 0.08 |
CHOox (mg/kgFFM per minute) | 2.33 ± 0.69 | 1.72 ± 0.83 | 0.19 | 2.70 ± 1.24 | 1.90 ± 1.17 | 0.02 |
Table 3 Change in substrate metabolism from basal (resting and fasting) to insulin-stimulation conditions pre-intervention and after 6 mo of energy restriction or exercise training (post-intervention)
Energy restriction (n = 6) | Exercise (n = 10) | |||||
Pre | Post | P | Pre | Post | P | |
Δ Respiratory quotient | 0.05 ± 0.05 | 0.08 ± 0.05 | 0.58 | 0.04 ± 0.02 | 0.07 ± 0.05 | 0.11 |
Δ Fatox (mg/kgFFM per minute) | -0.29 ± 0.46 | -0.56 ± 0.32 | 0.31 | -0.24 ± 0.36 | -0.55 ± 0.35 | 0.06 |
Δ CHOox (mg/kgFFM per minute) | 0.92 ± 0.98 | 1.41 ± 0.98 | 0.46 | 0.54 ± 0.85 | 1.02 ± 0.93 | 0.18 |
Table 4 Maximal aerobic power and substrate oxidation during exercise pre-intervention, and after 6 mo of energy restriction or exercise treatment (post-intervention)
Energy restriction (n = 6) | Exercise (n = 10) | |||||
Pre | Post | P | Pre | Post | P | |
VO2peak (mL/kg per minute) | 20.4 ± 5.1 | 20.7 ± 6.4 | 0.73 | 23.9 ± 6.4 | 28.3 ± 6.3 | < 0.001 |
VO2peak (mL/kgFFM per minute) | 32.5 ± 5.0 | 31.0 ± 5.4 | 0.31 | 39.2 ± 8.4 | 43.6 ± 7.4 | 0.004 |
Workload at VO2peak (W) | 121 ± 53 | 121 ± 57 | 0.94 | 176 ± 78 | 224 ± 81 | < 0.001 |
MFO (g/min) | 0.14 ± 0.13 | 0.06 ± 0.04 | 0.17 | 0.17 ± 0.09 | 0.29 ± 0.14 | 0.03 |
MFO (mg/kgFFM per minute) | 2.5 ± 1.7 | 1.2 ± 0.7 | 0.18 | 2.8 ± 1.5 | 4.4 ± 1.9 | 0.04 |
Workload at MFO (W) | 44.8 ± 16.5 | 41.3 ± 13.4 | 0.43 | 44.7 ± 19.5 | 76.3 ± 46.0 | 0.03 |
Fatmax (%VO2peak) | 48.7 ± 14.7 | 47.9 ± 8.8 | 0.62 | 45.2 ± 12.3 | 47.0 ± 7.2 | 0.94 |
- Citation: Croci I, Byrne NM, Chachay VS, Hills AP, Clouston AD, O’Moore-Sullivan TM, Prins JB, Macdonald GA, Hickman IJ. Independent effects of diet and exercise training on fat oxidation in non-alcoholic fatty liver disease. World J Hepatol 2016; 8(27): 1137-1148
- URL: https://www.wjgnet.com/1948-5182/full/v8/i27/1137.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i27.1137